口服尼可地尔预防桡动脉途径介入诊疗中桡动脉痉挛作用的临床研究

高波, 贺莉, 肖杰, 等. 口服尼可地尔预防桡动脉途径介入诊疗中桡动脉痉挛作用的临床研究[J]. 临床心血管病杂志, 2014, 30(6): 495-497. doi: 10.13201/j.issn.1001-1439.2014.06.010
引用本文: 高波, 贺莉, 肖杰, 等. 口服尼可地尔预防桡动脉途径介入诊疗中桡动脉痉挛作用的临床研究[J]. 临床心血管病杂志, 2014, 30(6): 495-497. doi: 10.13201/j.issn.1001-1439.2014.06.010
GAO Bo, HE Li, XIAO Jie, et al. Clinical study of the preventive role of oral nicorandil on artery spasm in transradial radial interventing treatment[J]. J Clin Cardiol, 2014, 30(6): 495-497. doi: 10.13201/j.issn.1001-1439.2014.06.010
Citation: GAO Bo, HE Li, XIAO Jie, et al. Clinical study of the preventive role of oral nicorandil on artery spasm in transradial radial interventing treatment[J]. J Clin Cardiol, 2014, 30(6): 495-497. doi: 10.13201/j.issn.1001-1439.2014.06.010

口服尼可地尔预防桡动脉途径介入诊疗中桡动脉痉挛作用的临床研究

详细信息
    通讯作者: 顾晔,E-mail:yegu2003cn@163.com
  • 中图分类号: R541.4

Clinical study of the preventive role of oral nicorandil on artery spasm in transradial radial interventing treatment

More Information
  • 目的:观察术前应用尼可地尔口服制剂在经桡动脉途径介入诊疗中预防桡动脉痉挛 (radial artery spasm, RAS) 的疗效及安全性。方法:选择经桡动脉途径介入检查和治疗的患者400例, 随机分成尼可地尔组 (术前给予尼可地尔片5mg口服) 和对照组, 比较两组RAS发生率, 并观察尼可地尔的不良反应。结果:实际入选病例分为尼可地尔组198例, 对照组199例。完成单纯冠状动脉 (冠脉) 造影 (CAG) 和冠脉介入治疗 (CAG+PCI) 的例数, 两组无统计学差异。行单纯CAG, 尼可地尔组RAS发生率低于对照组 (9.7%:20.8%, P<0.05);行CAG+PCI, 尼可地尔组与对照组RAS发生率差异无统计学意义 (17.2%:23.2%, P>0.05);但总和RAS发生率, 尼可地尔组与对照组比较, 差异有统计学意义 (12.1%:21.6%, P<0.05)。尼可地尔组不良反应发生率低且轻微。结论:经桡动脉途径冠脉介入诊疗术前口服尼可地尔能安全、有效地预防单纯CAG桡动脉痉挛的发生, 但不能有效预防CAG+PCI桡动脉痉挛。
  • 加载中
  • [1]

    CHEN C W, LIN C L, LIN T K, et al.A simple and effective regimen for prevention of radial artery spasm during coronary catheterization[J].Cardiology, 2006, 105:43-47.

    [2]

    KIM S H, KIM E J, CHEON W S, et al.Comparative study of nicorandil and a spasmolytic cocktail in preventing radial artery spasm during transradial coronary angiography[J].Int J Cardiol, 2007, 120:325-330.

    [3]

    CARRILLO X, MAURI J, FERNANDEZ-NOFRERIAS E, et al.Safety and efficacy of transradial access in coronary angiography:8-year experience[J].J Invasive Cardiol, 2012, 24:346-351.

    [4]

    钟继明, 李浪, 陆永光, 等.经桡动脉冠心病介入诊疗中桡动脉痉挛的发生及其预测因素[J].介入放射学杂志, 2011, 20 (4):265-268.

    [5]

    ERCAN S, UNAL A, ALTUNBAS G, et al.Anxiety score as a risk factor for radial artery vasospasm during radial interventions:apilot study[J].Angiology, 2014, 65:67-70.

    [6]

    TUNCEZ A, KAYA Z, ARAS D, et al.Incidence and predictors of radial artery occlusion associated transradial catheterization[J].Int J Med Sci, 2013, 10:1715-1719.

    [7]

    BOYER N, BEYER A, GUPTA V, et al.The effects of intra-arterial vasodilators on radial artery size and spasm:implications for contemporary use of trans-radial access for coronary angiography and percutaneous coronary intervention[J].Cardiovasc Revasc Med, 2013, 14:321-324.

    [8]

    CARRILLO X, FERNANDEZ-NOFRERIAS E, CIOMPI F, et al.Changes in radial artery volume assessed using intravascular ultrasound:a comparison of two vasodilator regimens in transradial coronary interventions[J].J Invasive Cardiol, 2011, 23:401-404.

    [9]

    DHARMA S, SHAH S, RADADIYA R, et al.Nitroglycerin plus diltiazem versus nitroglycerin alone for spasm prophylaxis with transradial approach[J].J Invasive Cardiol, 2012, 24:122-125.

  • 加载中
计量
  • 文章访问数:  143
  • PDF下载数:  98
  • 施引文献:  0
出版历程
收稿日期:  2014-05-05

目录